BUHLMANN News - Buhlmann Diagnostics Corp - Newsletter - Tradeshow


Clinical trial of the use of the smartphone-based health applications IBDsmart and IBDoc

IBDoc® Citation: ECCO 2019 Poster Walmsley et al. Poster: P630 A non-inferiority randomised clinical trial of the use of the smartphone-based ...
Read More

IBDoc Learning with Video Tutorials

New IBDoc® Tutorials (available on: ibdoc.net) IBDoc® Portal Tutorial videos offer:
  • Quick and easy training for the sites to ...
    Read More

BÜHLMANN fCAL® turbo Success Story- Freeman Hospital, Newcastle

The Benefits of Switching to BÜHLMANN Assay for Calprotectin Testing Dr. Elodie Hanon, Prinicpal Clinial Scientist at the Freeman Hospital, ...
Read More

BÜHLMANN Laboratories AG Receives FDA Clearance for CALEX®Cap Calprotectin Extraction Device

BÜHLMANN CALEX® Cap, a single use tube intended for the preparation of human stool samples to be used with the ...
Read More

Four Years of Experience Using IBDoc

Benefits for Patients and Healthcare Staff of Routine IBDoc® Use Kathleen Sugrue, Advanced Nurse Practitioner at Mercy University Hospital, Cork ...
Read More

Patient’s Perspective- One Year using IBDoc

Read a recent article written from the perspective of a long term Crohn's sufferer who shares his experience of managing ...
Read More

BÜHLMANN Laboratories AG Receives FDA Clearance for its fCAL® turbo Automated Calprotectin Test

BÜHLMANN fCAL® turbo, an in vitro diagnostic assay intended for the quantitation of calprotectin in human stool, has received 510(k) ...
Read More

Calprotectin in the Updated ACG Ulcerative Colitis Guidelines

What is Ulcerative colitis? Ulcerative colitis (UC) is a chronic disease affecting the large intestine, in which the lining of ...
Read More